Skip to main content

Advertisement

SpringerLink
Log in

A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

The MIG-SCOG is a questionnaire to assess self-reported subjective cognitive symptoms during migraine attacks, consisting of 9 items evaluating executive functions and language. The aim of the study was to evaluate the psychometric properties of the Italian version of the MIG-SCOG (I-MIG-SCOG) in patients with migraine without aura.

Methods

The I-MIG-SCOG underwent 20 Italian healthy subjects to assess its comprehensibility. Reliability and divergent validity of the I-MIG-SCOG were evaluated in a sample of 153 migraines without aura patients. They also underwent Montreal Cognitive Assessment, Beck Depression Inventory and Apathy Evaluation Scale.

Results

The final I-MIG-SCOG was easily comprehensible. There were no missing data, no floor and ceiling effects; mean I-MIG-SCOG score was 7.54 ± 3.98; Cronbach’s alpha was 0.814. The I-MIG-SCOG score correlated poorly with Montreal Cognitive Assessment, Beck Depression Inventory and Apathy Evaluation Scale.

Conclusion

The I-MIG-SCOG should represent a reliable and valid patient-centred and disease-related instrument to identify cognitive symptoms experienced during migraine attacks and to monitor the divergent effects of symptomatic treatments on cognitive functions also in Italian migraine patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basáñez MG, Buckle G, Budke CM, Carabin H, Fèvre EM, Fürst T, Halasa YA, King CH, Murdoch ME, Ramaiah KD, Shepard DS, Stolk WA, Undurraga EA, Stanaway JD, Naghavi M, Murray CJL (2017) The global burden of disease study 2013: what does it mean for the NTDs? PLoS Negl Trop Dis 11(8):e0005424

    Article  Google Scholar 

  2. Ford JH, Jackson J, Milligan G et al (2017) A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache 57(10):1532–1544

    Article  Google Scholar 

  3. Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 154(Suppl. 1):S44–S53

    Article  CAS  Google Scholar 

  4. Gil-Gouveia R, Oliveira AG, Martins IP (2016) The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia 36(5):422–430

    Article  Google Scholar 

  5. Vuralli D, Ayata C, Bolay H. Cognitive dysfunction and migraine. J Headache Pain 2018;15;19(1):109

  6. Gil-Gouveia R, Oliveira AG, Martins IP (2015) Cognitive dysfunction during migraine attacks: a study on migraine without aura. Cephalalgia 35:662–674

    Article  Google Scholar 

  7. Gil-Gouveia R, Oliveira AG, Martins IP (2011) A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: development and validation. Cephalalgia 31(9):984–991

    Article  Google Scholar 

  8. Gil-Gouveia R, Oliveira AG, Pavão MI (2016) Clinical utility of the Mig-SCog. Headache 56(6):941–951

    Article  Google Scholar 

  9. Headache classification committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd ed. (beta version). Cephalalgia 2013;33: 629–808, The International Classification of Headache Disorders, 3rd edition (beta version)

  10. Santangelo G, Siciliano M, Pedone R, Vitale C, Falco F, Bisogno R, Siano P, Barone P, Grossi D, Santangelo F, Trojano L (2015) Normative data for the Montreal cognitive assessment in an Italian population sample. Neurol Sci 36(4):585–559

    Article  Google Scholar 

  11. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 67(3):588–597

    Article  CAS  Google Scholar 

  12. Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the apathy evaluation scale. Psychiatry Res 38(2):143–162

    Article  CAS  Google Scholar 

  13. Stewart WF, Lipton RB, Dowson AJ et al (2001) Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20–S28

    Article  CAS  Google Scholar 

  14. Huang L, Juan Dong H, Wang X, Wang Y, Xiao Z (2017) Duration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event-related potentials. J Headache Pain 18(1):54

    Article  Google Scholar 

  15. Schmitz N, Arkink EB, Mulder M et al (2008) Frontal lobe structure and executive function in migraine patients. Neurosci Lett 440(2):92–96

    Article  CAS  Google Scholar 

  16. Russo A, Tessitore A, Giordano A, Corbo D, Marcuccio L, de Stefano M, Salemi F, Conforti R, Esposito F, Tedeschi G (2012) Executive resting-state network connectivity in migraine without aura. Cephalalgia 32(14):1041–1048

    Article  Google Scholar 

  17. Tessitore A, Russo A, Conte F, Giordano A, de Stefano M, Lavorgna L, Corbo D, Caiazzo G, Esposito F, Tedeschi G (2015) Abnormal connectivity within executive resting-state network in migraine with Aura. Headache 55(6):794–805

    Article  Google Scholar 

  18. González-Hernández A, Marichal-Cancino BA (2018) Maassen Van Den Brink A et al. Side effects associated with current and prospective antimigraine pharmacotherapies. Expert Opin Drug Metab Toxicol 14(1):25–41

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, University of Campania “Luigi Vanvitelli”, 80138, Naples, Italy

    Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Fabrizio Scotto di Clemente & Gioacchino Tedeschi

  2. Institute for Diagnosis and Care “Hermitage Capodimonte”, 80100, Naples, Italy

    Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Fabrizio Scotto di Clemente, Gioacchino Tedeschi & Gabriella Santangelo

  3. Department of Psychology, University of Campania “Luigi Vanvitelli”, 81100, Caserta, Italy

    Federica Garramone, Maria Cropano, Luigi Trojano & Gabriella Santangelo

  4. ICS Maugeri, Institute of TeleseIRCCS, 82037, Telese Terme, (BN), Italy

    Luigi Trojano

Authors
  1. Antonio Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcello Silvestro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Garramone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Tessitore
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Cropano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fabrizio Scotto di Clemente
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luigi Trojano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gioacchino Tedeschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gabriella Santangelo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio Russo.

Ethics declarations

Disclosure of potential conflicts of interest

Dott. Russo has received speaker honoraria from Allergan and serves as an Associate Editor of Frontiers in Neurology (section Headache Medicine and Facial Pain). Prof. Tessitore has received speaker honoraria from Novartis, Schwarz Pharma/UCB, Lundbeck, Abbvie and Glaxo. Prof. Tedeschi has received speaker honoraria from Sanofi-Aventis, Merck Serono, Bayer Schering Pharma, Novartis, Biogen-Dompe` AG; has received funding for travel from Bayer Schering Pharma, Biogen-Dompe’AG, Merck Serono, Novartis and Sanofi Aventis; and serves as an Associate Editor of Neurological Sciences.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the research committee of the University of Campania “Luigi Vanvitelli”and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Russo, A., Silvestro, M., Garramone, F. et al. A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG. Neurol Sci 41, 1139–1143 (2020). https://doi.org/10.1007/s10072-019-04200-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04200-y

Keywords

Search

Navigation